NASDAQ:MCRB - Seres Therapeutics Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $6.00 -0.11 (-1.80 %) (As of 02/20/2019 05:59 AM ET)Previous Close$6.11Today's Range$5.80 - $6.2452-Week Range$4.42 - $10.32Volume114,800 shsAverage Volume125,063 shsMarket Capitalization$245.16 millionP/E RatioN/ADividend YieldN/ABeta1.84 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Seres Therapeutics (NASDAQ:MCRB) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.5 Wall Street analysts have issued ratings and price targets for Seres Therapeutics in the last 12 months. Their average twelve-month price target is $15.3333, suggesting that the stock has a possible upside of 155.56%. The high price target for MCRB is $16.00 and the low price target for MCRB is $15.00. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.602.502.502.71Ratings Breakdown: 1 Sell Rating(s)0 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)0 Hold Rating(s)3 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)0 Hold Rating(s)3 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)0 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $15.3333$15.3333$15.3333$19.25Price Target Upside: 155.56% upside92.63% upside72.67% upside159.78% upsideSeres Therapeutics (NASDAQ:MCRB) Consensus Price Target History Seres Therapeutics (NASDAQ:MCRB) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails2/8/2019CowenReiterated RatingBuyLow11/23/2018Cantor FitzgeraldReiterated RatingOverweightHigh11/9/2018OppenheimerSet Price TargetBuy$16.00High10/28/2018Chardan CapitalReiterated RatingBuyMedium8/3/2018Bank of AmericaDowngradeNeutral ➝ UnderperformHigh10/13/2017CIBCInitiated CoverageOutperform ➝ Outperform$19.00N/A10/12/2017CitigroupInitiated CoverageOutperform ➝ Positive$19.00N/A10/6/2017Seaport Global SecuritiesReiterated RatingBuy$20.00N/A8/4/2017HC WainwrightReiterated RatingBuy ➝ Buy$15.00 ➝ $19.00High8/3/2017Canaccord GenuitySet Price TargetBuy$20.00Low3/20/2017FBR & CoReiterated RatingOutperform$18.00Low(Data available from 2/20/2017 forward) This page was last updated on 2/20/2019 by MarketBeat.com StaffFeatured Article: What is a balanced fund?